Spear Bio

Ultra-Sensitive Biomarker Detection

Boston, United States · Founded 2021 · $45.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Website
spear.bio
Total Funding
$45.0M
Last Round
$45.0M Series AJul 2024
Rounds
3

About

Spear Bio develops ultra-sensitive immunoassay kits and services based on its patented SPEAR (Successive Proximity Extension Amplification Reaction) technology. The wash-free, homogeneous platform detects protein biomarkers at attomolar concentrations using 1 µL or less of sample and a standard qPCR workflow, enabling research in neurological diseases including Alzheimer's, TBI, multiple sclerosis, and ALS.

Summary

Spear Bio is a Biotech company based in Boston, United States, founded in 2021. It has raised $45.0M in total across 3 rounds, most recently a $45.0M Series A round in Jul 2024. Investors include Maverick Ventures, CDH Investments and Foresite Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJul 2024
$45.0M

Sign up to see all 3 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Spear Bio on Indexed.vc
<a href="https://indexed.vc/companies/spear-bio"><img src="https://indexed.vc/api/badge/company/spear-bio" alt="Spear Bio on Indexed.vc" width="260" height="76" /></a>